Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
letter
. 1985 May 18;290(6480):1515. doi: 10.1136/bmj.290.6480.1515

Alternative to the digitalis glycosides for heart failure.

P Wilmshurst
PMCID: PMC1415682  PMID: 3922555

Full text

PDF

Page 1515

1515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benotti J. R., Grossman W., Braunwald E., Davolos D. D., Alousi A. A. Hemodynamic assessment of amrinone. A new inotropic agent. N Engl J Med. 1978 Dec 21;299(25):1373–1377. doi: 10.1056/NEJM197812212992501. [DOI] [PubMed] [Google Scholar]
  2. DiBianco R., Shabetai R., Silverman B. D., Leier C. V., Benotti J. R. Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study. J Am Coll Cardiol. 1984 Nov;4(5):855–866. doi: 10.1016/s0735-1097(84)80044-3. [DOI] [PubMed] [Google Scholar]
  3. Endoh M., Yamashita S., Taira N. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. J Pharmacol Exp Ther. 1982 Jun;221(3):775–783. [PubMed] [Google Scholar]
  4. Firth B. G., Ratner A. V., Grassman E. D., Winniford M. D., Nicod P., Hillis L. D. Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol. Am J Cardiol. 1984 Dec 1;54(10):1331–1336. doi: 10.1016/s0002-9149(84)80092-2. [DOI] [PubMed] [Google Scholar]
  5. Gaide M. S., Fitterman W. S., Wiggins J. R., Myerburg R. J., Cameron J. S., Bassett A. L. Amrinone relaxes potassium-induced contracture of failing right ventricular muscle of cats. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):335–340. doi: 10.1097/00005344-198303000-00028. [DOI] [PubMed] [Google Scholar]
  6. Hermiller J. B., Leithe M. E., Magorien R. D., Unverferth D. V., Leier C. V. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. J Pharmacol Exp Ther. 1984 Feb;228(2):319–326. [PubMed] [Google Scholar]
  7. Honerjäger P., Schäfer-Korting M., Reiter M. Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence. Naunyn Schmiedebergs Arch Pharmacol. 1981 Dec;318(2):112–120. doi: 10.1007/BF00508835. [DOI] [PubMed] [Google Scholar]
  8. Kinney E. L., Carlin B., Ballard J. O., Burks J. M., Hallahan W. F., Zelis R. Clinical experience with amrinone in patients with advanced congestive heart failure. J Clin Pharmacol. 1982 Oct;22(10):433–440. doi: 10.1002/j.1552-4604.1982.tb02632.x. [DOI] [PubMed] [Google Scholar]
  9. Levine S. D., Jacoby M., Satriano J. A., Schlondorff D. The effects of amrinone on transport and cyclic AMP metabolism in toad urinary bladder. J Pharmacol Exp Ther. 1981 Feb;216(2):220–224. [PubMed] [Google Scholar]
  10. Marcus M. L., Skelton C. L., Grauer L. E., Epstein S. E. Effects of theophylline on myocardial mechanics. Am J Physiol. 1972 Jun;222(6):1361–1365. doi: 10.1152/ajplegacy.1972.222.6.1361. [DOI] [PubMed] [Google Scholar]
  11. Meisheri K. D., Palmer R. F., Van Breemen C. The effects of amrinone on contractility, Ca2+ uptake and cAMP in smooth muscle. Eur J Pharmacol. 1980 Jan 25;61(2):159–165. doi: 10.1016/0014-2999(80)90158-2. [DOI] [PubMed] [Google Scholar]
  12. Opie L. H. Principles of therapy for congestive heart failure. Eur Heart J. 1983 Jan;4 (Suppl A):199–208. doi: 10.1093/eurheartj/4.suppl_a.199. [DOI] [PubMed] [Google Scholar]
  13. Packer M., Medina N., Yushak M. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. Circulation. 1984 Dec;70(6):1038–1047. doi: 10.1161/01.cir.70.6.1038. [DOI] [PubMed] [Google Scholar]
  14. Scholz H. Inotropic drugs and their mechanisms of action. J Am Coll Cardiol. 1984 Aug;4(2):389–397. doi: 10.1016/s0735-1097(84)80231-4. [DOI] [PubMed] [Google Scholar]
  15. Wilmshurst P. T., Thompson D. S., Jenkins B. S., Coltart D. J., Webb-Peploe M. M. Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function. Br Heart J. 1983 Jan;49(1):77–82. doi: 10.1136/hrt.49.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wilmshurst P. T., Walker J. M., Fry C. H., Mounsey J. P., Twort C. H., Williams B. T., Davies M. J., Webb-Peploe M. M. Inotropic and vasodilator effects of amrinone on isolated human tissue. Cardiovasc Res. 1984 May;18(5):302–309. doi: 10.1093/cvr/18.5.302. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES